Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a confirmatory, randomized, placebo-controlled, multi-center, double-blinded phase
II/III study. The study population consists of male or female intensive care unit (ICU)
patients with a need for mechanical ventilation for more than 48 hours, aged between 18 and
80 years.